Product Details

Verofur is a sterile injectable formulation that meets British Pharmacopoeia (BP) standards. Specifically, it delivers Furosemide at 10mg/mL for use as a loop diuretic through the intramuscular (I.M.) or intravenous (I.V.) route. As a result, it offers rapid diuretic action for the management of fluid overload in acute and chronic settings.

The injection contains:

• Furosemide BP (10mg per mL) – A loop diuretic that inhibits the Na-K-Cl cotransporter in the thick ascending limb of the loop of Henle. Consequently, it blocks sodium and chloride reabsorption, producing a rapid and potent diuretic effect.

Physicians use Verofur for the treatment of oedema associated with congestive heart failure, hepatic cirrhosis, and renal disease, as well as for acute pulmonary oedema where rapid fluid removal is essential. In addition, its dual-route (I.M./I.V.) formulation allows flexible administration based on clinical urgency. Because of this, Verofur suits hospitals, ICUs, and emergency departments where fast-acting diuresis is required.

Key Features:

• Overall, this BP-compliant formulation guarantees pharmaceutical-grade purity
• Additionally, the dual-route (I.M./I.V.) formulation offers flexible clinical use
• Furthermore, each ampoule delivers precise, validated dosage accuracy at 20mg/2mL
• Notably, rigorous purity and sterility testing backs every stage of manufacturing
• Beyond that, light-protected ampoule packaging preserves product stability during storage
• Ultimately, a reliable supply chain suits bulk distribution to hospitals, clinics, and pharmacies